Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Larson

Showing results (101-110 of 383) with videos related to

Pageof 39
Sort By:
Pediatric Blood & Cancer|November 6, 2018
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance)Matthew A Kutny, Susan Geyer, Kristina M Laumann, et al.
Cancer Chemotherapy and Pharmacology|September 15, 2005
Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B studyCheri E Klein, Helen Kastrissios, Antonius A Miller, et al.
Blood|April 23, 2008
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibilityNathan A Ellis, Dezheng Huo, Ozlem Yildiz, et al.
Cancer|September 16, 2004
Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literatureWilliam Blum, Krzysztof Mrózek, Amy S Ruppert, et al.
Blood|February 1, 2007
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511Meir Wetzler, Ben L Sanford, Joanne Kurtzberg, et al.
American Journal of Hematology|November 4, 2015
Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trialsJorge J Castillo, Flora Mulkey, Susan Geyer, et al.
Leukemia & Lymphoma|August 18, 2012
The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)Melhem Solh, Kanti R Rai, Bercedis L Peterson, et al.
Leukemia & Lymphoma|May 3, 2008
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107Meir Wetzler, Kathleen A Donohue, Olatoyosi M Odenike, et al.
JACC. Cardiooncology|October 10, 2022
Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular ToxicityBrian Yu, Afaf E G Osman, Nikola Sladojevic, et al.
Leukemia|February 5, 2021
Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemiaAndrew H Wei, Josep-Maria Ribera, Richard A Larson, et al.
Pageof 39

Showing results (101-110 of 383) with videos related to

Sort By:
Pageof 39
Pediatric Blood & Cancer|November 6, 2018
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance)Matthew A Kutny, Susan Geyer, Kristina M Laumann, et al.
Cancer Chemotherapy and Pharmacology|September 15, 2005
Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B studyCheri E Klein, Helen Kastrissios, Antonius A Miller, et al.
Blood|April 23, 2008
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibilityNathan A Ellis, Dezheng Huo, Ozlem Yildiz, et al.
Cancer|September 16, 2004
Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literatureWilliam Blum, Krzysztof Mrózek, Amy S Ruppert, et al.
Blood|February 1, 2007
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511Meir Wetzler, Ben L Sanford, Joanne Kurtzberg, et al.
American Journal of Hematology|November 4, 2015
Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trialsJorge J Castillo, Flora Mulkey, Susan Geyer, et al.
Leukemia & Lymphoma|August 18, 2012
The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)Melhem Solh, Kanti R Rai, Bercedis L Peterson, et al.
Leukemia & Lymphoma|May 3, 2008
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107Meir Wetzler, Kathleen A Donohue, Olatoyosi M Odenike, et al.
JACC. Cardiooncology|October 10, 2022
Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular ToxicityBrian Yu, Afaf E G Osman, Nikola Sladojevic, et al.
Leukemia|February 5, 2021
Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemiaAndrew H Wei, Josep-Maria Ribera, Richard A Larson, et al.
Pageof 39